Selphos poisoning

Reading File
Finding Sources
Searching PubMed

"aluminium phosphide" AND poisoning

Searching the Web

Selphos aluminium phosphide poisoning management treatment 2024

Reading File
Reading File
Reading File
Finding Sources
I now have comprehensive information. Let me compile the full answer.

Selphos (Aluminium Phosphide) Poisoning

Selphos is one of several trade names for aluminium phosphide (AlP) tablets - others include Celphos, Alphos, Phostoxin, and Fumigran. It is infamous as "the agent of sure death" due to its extremely high mortality rate and the absence of a specific antidote.

Formulation

  • Gray-green tablets, each weighing 3 g, containing 56% active ingredient mixed with urea and ammonium carbonate
  • Each tablet liberates 1 g of phosphine gas (PH3)
  • Primarily used as a grain fumigant to destroy insects and rodents in stored grain

Mechanism of Toxicity

On contact with moisture (atmospheric humidity or gastric acid):
AlP + 3H2O → Al(OH)3 + PH3 (phosphine gas)
Phosphine is the actual toxic agent. It causes:
  • Mitochondrial dysfunction - inhibits cytochrome c oxidase (complex IV), blocking cellular respiration
  • Oxidative stress - generates reactive oxygen species, lipid peroxidation
  • Inhibits multiple enzyme systems including catalase and cholinesterase
  • Results in multi-organ failure: cardiovascular collapse is the principal cause of death

Fatal Dose and Period

ParameterValue
Fatal dose4-5 g (1-3 tablets)
Fatal period12-36 hours

Signs and Symptoms

Gastrointestinal (early):
  • Nausea, vomiting, burning epigastric pain
  • Intense thirst and diarrhoea
  • Garlicky/fishy odour from breath (characteristic)
Cardiovascular:
  • Hypotension and shock
  • ECG abnormalities: sinus tachycardia, bradycardia, heart block
  • Arrhythmias
  • Myocardial damage, pericarditis, congestive cardiac failure
Respiratory:
  • Tightness in chest, dyspnoea
  • Severe pulmonary oedema (from inhaled phosphine)
  • Respiratory distress in terminal stages
Neurological/Metabolic:
  • Excitement and agitation (early)
  • Hypocalcaemia, tetany, convulsions, coma
  • Oliguria
  • Metabolic acidosis
  • Cold clammy skin
Terminal event: Death from cardiac failure
  • P C Dikshit Textbook of Forensic Medicine and Toxicology, p. 573-574
  • Parikh's Textbook of Medical Jurisprudence Forensic Medicine and Toxicology, p. 679

Diagnosis

Clinical:
  • History of ingestion / exposure
  • Characteristic garlicky odour
Chemical test (bedside):
  • Ask the patient to breathe on filter paper impregnated with 0.1 N silver nitrate for 5-10 minutes
  • Paper turns black if phosphine is present (silver nitrate is reduced to metallic silver)
Lab:
  • Serial blood phosphine levels
  • ABG (metabolic acidosis), serum electrolytes, ECG monitoring
  • Serum magnesium, calcium
  • Cardiac enzymes (myocardial damage)
  • NT-proBNP (predictive biomarker for mortality)

Management

There is NO specific antidote.

Immediate / Decontamination

  • Remove patient from source of exposure
  • Wash skin with soap and water (AlP can absorb through skin)
  • Healthcare workers must use full-face masks and gloves - do NOT perform mouth-to-mouth; phosphine off-gassing from vomit is hazardous
  • Gastric lavage with 3-5% sodium bicarbonate, 1% copper sulphate, 1% potassium permanganate, or mineral/coconut oil - these convert AlP to phosphate within 30 minutes
    • Note: Some recent evidence questions routine gastric lavage since moisture contact during the procedure may accelerate phosphine generation
  • Oil-based decontamination (coconut oil) has shown benefit in some studies; a 2024 systematic review and meta-analysis supports oil-based gastric lavage

Supportive Treatment

ProblemIntervention
ArrhythmiasMagnesium sulphate 3 g IV bolus, then 6 g infusion over 24 h for 5-7 days
Hypocalcaemia/tetanyIntravenous calcium salts
Metabolic acidosisSodium bicarbonate 50 mEq q15 min until arterial HCO3 > 15 mmol/L
HypotensionIV fluids (0.9% NaCl bolus); low-dose dopamine infusion
Pulmonary oedemaCorticosteroids; oxygen; positive pressure ventilation/intubation
BronchospasmAerosol bronchodilators
InfectionAntibiotics
Oxidative stressAntioxidants (N-acetylcysteine, glutathione, Vitamin E) - used adjunctively

Emerging/Investigated Therapies

  • Intravenous lipid emulsion (ILE) - shown benefit in case reports and a 2024 RCT (acts as lipid sink for lipophilic phosphine)
  • Glucose-insulin-potassium (GIK) infusion - pilot RCT showed some benefit for myocardial support
  • High-dose insulin therapy - under study (RCT published 2024)
  • Hyperbaric oxygen therapy - rare successful cases reported; limited evidence
  • Monitoring for 72 hours minimum; continuous cardiac monitoring mandatory

Medicolegal Aspects

  • Common method of suicide in rural India, especially in Haryana, Punjab, Uttar Pradesh, and Rajasthan
  • Used in dowry deaths (homicidal poisoning) in rural India - only a fragment of a tablet is sufficient
  • The resemblance of tablets to medicinal preparations makes accidental ingestion possible
  • Autopsy findings include congestion of all organs and frothy fluid in airways

Key Points to Remember

  1. Phosphine is the actual toxin, not AlP itself
  2. Garlicky/fishy breath odour is the clinical hallmark
  3. No antidote exists - all treatment is supportive
  4. Cardiac failure (cardiogenic shock) is the primary cause of death
  5. Magnesium sulphate is the cornerstone drug for arrhythmias
  6. Coconut/mineral oil lavage may reduce phosphine liberation in the stomach
  7. High mortality even with aggressive ICU care

Recent evidence note: A 2025 review (PMID 41523401) specifically addresses neurological manifestations of AlP poisoning, an underappreciated aspect. A 2024 systematic review supports oil-based gastric decontamination. High-dose insulin and ILE are being studied in RCTs as adjuncts.

Harrison based

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have enough from Harrison's. Here is an honest, Harrison-based answer:

Selphos (Aluminium Phosphide) Poisoning - Harrison's 22E Perspective

Important clarification upfront

Harrison's Principles of Internal Medicine 22E does not have a dedicated section on aluminium phosphide / Selphos poisoning. The toxicology chapter (Chapter 470, "Poisoning and Drug Overdose") explicitly states that "Poisonings not covered in this chapter are discussed in specialized texts." AlP poisoning is not among its covered syndromes - it focuses on poisonings common in a Western context (acetaminophen, opioids, alcohol, carbon monoxide, etc.).
What Harrison's does provide is the general framework for managing any poisoning, which directly applies to Selphos. Here is how that framework maps onto AlP poisoning:

Harrison's General Framework Applied to Selphos Poisoning

1. Treatment Goals (Harrison's Table 470-3)

Harrison's defines five universal goals:
GoalApplication to Selphos
Support vital signsMaintain BP, treat arrhythmias, ventilate
Prevent further absorptionGI decontamination (oil/bicarbonate lavage)
Enhance eliminationSupportive; no established extracorporeal method
Administer antidotesNone exist for AlP
Prevent re-exposurePsychiatric referral (suicidal ingestion), regulatory notification

2. Supportive Care (Harrison's priority)

Harrison's emphasises this is the backbone of all poisoning management:
  • Airway protection - early intubation if respiratory distress or pulmonary oedema develops
  • Oxygenation/ventilation - oxygen for hypoxia; positive pressure ventilation for pulmonary oedema
  • Treatment of arrhythmias - magnesium sulphate is the agent of choice (IV 3 g bolus, then infusion)
  • Haemodynamic support - IV fluids, vasopressors (dopamine/noradrenaline) for refractory shock
  • Correction of metabolic derangements - sodium bicarbonate for metabolic acidosis; calcium for hypocalcaemia
  • Treatment of seizures - benzodiazepines
  • Prevention of secondary complications - ICU monitoring, treat infections

3. GI Decontamination (Harrison's principles)

Harrison's states decontamination should be selective, not routine, based on:
  • Time since ingestion (efficacy drops sharply after 1 hour)
  • Severity of expected toxicity
  • Risk of complications
For AlP specifically:
  • Activated charcoal - Harrison's preferred decontamination method generally, but its efficacy for AlP is uncertain (AlP is an inorganic compound; Harrison's notes that "charged chemicals and inorganic compounds are not well adsorbed by charcoal")
  • Gastric lavage - Harrison's reserves this for "life-threatening poisons not treatable by other means" - AlP qualifies. However, a unique concern with AlP is that adding moisture during lavage accelerates phosphine liberation; oil-based lavage (coconut oil/liquid paraffin) is preferred over water to avoid this
  • Skin decontamination - wash with soap and water (AlP is dermally absorbed)

4. Enhancement of Elimination

Harrison's lists: multiple-dose activated charcoal, urinary pH alteration, haemodialysis, haemoperfusion, CVVH, hyperbaric oxygen.
For AlP:
  • No extracorporeal method has proven effective for eliminating phosphine
  • Hyperbaric oxygen - listed by Harrison's as a modality; isolated case reports suggest benefit in AlP, though evidence remains very limited
  • Haemoperfusion/CVVH may assist multi-organ support, not phosphine elimination per se

5. Antidotes

Harrison's framework: "Neutralization by antibodies, chemical binding, metabolic antagonism, physiologic antagonism."
For AlP: No specific antidote exists. This is what makes Selphos poisoning so lethal. Agents used empirically include:
  • Magnesium sulphate (physiologic antagonism for arrhythmias)
  • N-acetylcysteine, glutathione (antioxidants - metabolic support)
  • Intravenous lipid emulsion (ILE) - emerging evidence; acts as a lipid sink
  • Glucose-insulin-potassium (GIK) - myocardial support
  • Sodium bicarbonate - metabolic antagonism of acidosis

6. Harrison's Global Considerations Note

Harrison's 22E (2025) specifically adds a Global Considerations note acknowledging that poisoning patterns differ globally - immigrants, travelers, and internet purchasing introduce agents uncommon in Western settings. AlP is a perfect example: it is the leading cause of pesticide suicide in South Asia and the Middle East but rarely encountered in North America/Europe.

Bottom Line

Harrison's does not address Selphos directly. For this topic, forensic medicine and toxicology texts (P.C. Dikshit, Parikh's) and emergency medicine references (Rosen's) are the authoritative sources. Harrison's framework for general poisoning management remains applicable and is consistent with what those texts recommend for AlP.
  • Harrison's Principles of Internal Medicine 22E, Chapter 470: Poisoning and Drug Overdose, pp. 3749-3758
This is a shared conversation. Sign in to Orris to start your own chat.